Recent Updates
Recently added Catalysts
ELDN Positive Sentiment

How pig organs may soon save lives

Key Takeaway: The article discusses the promising potential of using pig organs for transplantation, highlighting advancements in xenotransplantation that could alleviate organ shortages. It emphasizes the life-saving impact this technology may have for patients in need of transplants. The narrative includes patient stories and clinical trials that showcase the effectiveness of this innovative approach.
Price reaction · baseline $4.25 (2025-10-29T16:00:00.000Z) · hit during market hours · clean, no other ELDN news in the window
day 0 close · peak
0%

Market Sentiment Analysis

POSITIVE FACTORS

  • Potential for pig organs to address organ shortages.
  • Innovative approach to saving lives.
  • Advancements in xenotransplantation technology.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+90%
120-day peak, hindsight
Typical move
6.5%
average across 7 past catalysts
Cash runway
~11 mo
Medium dilution risk
Lead asset
AT-1501
Phase 2 · Kidney Transplant Rejection

Full Press Release Details

Transforming Lives. One Organ at a Time.
• Overview Focus Patient Stories Clinical Trials In The News
• Science Mechanism of Action Pipeline Publications & Presentations In The News
• Team Overview Leadership Board of Directors
• Investors Overview News & Events Press Releases Events Publications & Presentations Corporate Governance Governance Overview Committee Composition Ethics Hotline Financials SEC Filings Stock Information Stock Quote & Chart Analyst Coverage Resources Investor FAQs Email Alerts Contact IR
• Culture/Careers Culture Careers
• Contact
• Focus
• Patient Stories
• Clinical Trials
• In The News
• Mechanism of Action
• Pipeline
• Publications & Presentations
• In The News
• Overview
• Leadership
• Board of Directors
• Overview
• News & Events Press Releases Events Publications & Presentations
• Corporate Governance Governance Overview Committee Composition Ethics Hotline
• Financials SEC Filings
• Stock Information Stock Quote & Chart Analyst Coverage
• Resources Investor FAQs Email Alerts Contact IR
• Press Releases
• Events
• Publications & Presentations
• Governance Overview
• Committee Composition
• Ethics Hotline
• SEC Filings
• Stock Quote & Chart
• Analyst Coverage
• Investor FAQs
• Email Alerts
• Contact IR
• Culture
• Careers
• Privacy Overview
• Necessary
• Analytics
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.

Frequently Asked Questions

What is xenotransplantation?

Xenotransplantation is the process of transplanting organs from one species to another, such as from pigs to humans.

How can pig organs help with organ shortages?

Pig organs can potentially provide a sustainable source of transplants, addressing the critical shortage of human organs.

What are the benefits of using pig organs?

Using pig organs may reduce waiting times for transplants and improve outcomes for patients in need.

Are there any clinical trials for pig organ transplants?

Yes, there are ongoing clinical trials exploring the safety and effectiveness of pig organ transplants.

Last updated: Oct 29, 2025